As of 2024-07-27, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -6.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 285.70 mil USD. AVITA's TTM EBITDA according to its financial statements is -41.28 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 18.7x | 13.2x |
| Forward P/E multiples | 14.2x - 22.8x | 19.0x |
| Fair Price | (23.66) - (30.90) | (26.70) |
| Upside | -333.6% - -405.0% | -363.6% |
| Date | EV/EBITDA |
| 2024-07-26 | -6.92 |
| 2024-07-25 | -6.97 |
| 2024-07-24 | -6.88 |
| 2024-07-23 | -7.08 |
| 2024-07-22 | -6.78 |
| 2024-07-19 | -6.63 |
| 2024-07-18 | -6.82 |
| 2024-07-17 | -6.99 |
| 2024-07-16 | -7.09 |
| 2024-07-15 | -6.75 |
| 2024-07-12 | -6.44 |
| 2024-07-11 | -6.08 |
| 2024-07-10 | -5.78 |
| 2024-07-09 | -5.90 |
| 2024-07-08 | -5.77 |
| 2024-07-05 | -5.63 |
| 2024-07-03 | -5.46 |
| 2024-07-02 | -5.52 |
| 2024-07-01 | -5.42 |
| 2024-06-28 | -5.54 |
| 2024-06-27 | -5.56 |
| 2024-06-26 | -5.56 |
| 2024-06-25 | -5.55 |
| 2024-06-24 | -5.63 |
| 2024-06-21 | -5.70 |
| 2024-06-20 | -5.78 |
| 2024-06-18 | -5.60 |
| 2024-06-17 | -5.67 |
| 2024-06-14 | -5.82 |
| 2024-06-13 | -6.01 |
| 2024-06-12 | -6.12 |
| 2024-06-11 | -6.21 |
| 2024-06-10 | -6.25 |
| 2024-06-07 | -6.31 |
| 2024-06-06 | -6.57 |
| 2024-06-05 | -6.53 |
| 2024-06-04 | -6.12 |
| 2024-06-03 | -6.35 |
| 2024-05-31 | -6.60 |
| 2024-05-30 | -6.40 |
| 2024-05-29 | -6.10 |
| 2024-05-28 | -5.98 |
| 2024-05-24 | -5.65 |
| 2024-05-23 | -5.73 |
| 2024-05-22 | -5.92 |
| 2024-05-21 | -5.68 |
| 2024-05-20 | -5.70 |
| 2024-05-17 | -5.76 |
| 2024-05-16 | -5.54 |
| 2024-05-15 | -5.72 |